A potent, selective series of MMP-13 inhibitors has been derived from a weak (3.2 microM) inhibitor that did not bear a zinc chelator. Structure-based drug design strategies were employed to append a Zn-chelating group to one end of the molecule and functionality to enhance selectivity to the other. A compound from this series demonstrated rat oral bioavailability and efficacy in a bovine articular cartilage explant model.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2005.06.019 | DOI Listing |
Publication Analysis
Top Keywords
potent selective
8
mmp-13 inhibitors
8
identification potent
4
selective mmp-13
4
inhibitors potent
4
selective series
4
series mmp-13
4
inhibitors derived
4
derived weak
4
weak microm
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!